Filing Details
- Accession Number:
- 0001562180-18-004451
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-07 18:00:38
- Reporting Period:
- 2018-11-05
- Accepted Time:
- 2018-11-07 18:00:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590877 | Regenxbio Inc. | RGNX | Biological Products, (No Disgnostic Substances) (2836) | 471851754 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652824 | T. Kenneth Mills | C/O Regenxbio Inc. 9600 Blackwell Road, Suite 210 Rockville MD 20850 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-11-05 | 3,500 | $66.29 | 322,500 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-05 | 4,816 | $67.16 | 317,684 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-05 | 3,635 | $68.27 | 314,049 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-05 | 3,340 | $69.47 | 310,709 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-05 | 4,709 | $69.92 | 306,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $65.73 to $66.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $66.73 to $67.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $67.74 to $68.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $68.80 to $69.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $69.80 to $70.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
